FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

SCHWARTZ NORMAN D 		2. Issuer Name and Ticker or Trading Symbol

BIO RAD LABORATORIES INC [ BIO, BIOB ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Chairman, President, and CEO
(Last)          (First)          (Middle)

C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE 		3. Date of Earliest Transaction (MM/DD/YYYY)

9/10/2016
(Street)

HERCULES, CA 94547
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Bio-Rad A Common Stock                  411252   D  
 
Bio-Rad B Common Stock   9/10/2016     M    2000   (1) A $0   199763   D  
 
Bio-Rad B Common Stock   9/10/2016     F    1044   D $159.80   198719   D  
 
Bio-Rad B Common Stock   9/11/2016     M    5800   (1) A $0   204519   D  
 
Bio-Rad B Common Stock   9/11/2016     F    3027   D $159.80   201492   D  
 
Bio-Rad B Common Stock   9/12/2016     M    2617   (1) A $0   204109   D  
 
Bio-Rad B Common Stock   9/12/2016     F    1366   D $159.32   202743   D  
 
Bio-Rad B Common Stock                  12586   I   By Spouse   (2)
Bio-Rad B Common Stock                  4060054   I   By Blue Raven Partners, L.P.   (3)
Bio-Rad B Common Stock                  13726   I   By DANSA Partnership   (4)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units   $0   (5) 9/10/2016     M         2000      (6)   (6) Bio-Rad B Common Stock   2000   $0   6000   D  
 
Restricted Stock Units   $0   (5) 9/11/2016     M         2600      (7)   (7) Bio-Rad B Common Stock   2600   $0   5200   D  
 
Restricted Stock Units   $0   (5) 9/11/2016     M         3200      (8)   (8) Bio-Rad B Common Stock   3200   $0   12800   D  
 
Restricted Stock Units   $0   (5) 9/12/2016     M         2617      (9)   (9) Bio-Rad B Common Stock   2617   $0   2617   D  
 

Explanation of Responses:
( 1)  Shares of Class B common stock acquired on the vesting of restricted stock units.
( 2)  The reporting person disclaims beneficial ownership of these shares.
( 3)  The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
( 4)  The shares are held by a limited partnership of which the reporting person is a limited partner.
( 5)  Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock.
( 6)  The restricted stock units vest in five equal annual installments beginning September 10, 2015.
( 7)  The restricted stock units vest in five equal annual installments beginning September 11, 2014.
( 8)  The restricted stock units vest in five equal annual installments beginning September 11, 2016.
( 9)  The restricted stock units vest in five equal annual installments beginning September 12, 2013.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
SCHWARTZ NORMAN D
C/O BIO-RAD LABORATORIES, INC.
1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547 		X X Chairman, President, and CEO

Signatures
Norman D. Schwartz 9/13/2016
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Bio Rad Laboratories (NYSE:BIO.B)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Bio Rad Laboratories Charts.
Bio Rad Laboratories (NYSE:BIO.B)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Bio Rad Laboratories Charts.